This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
$107.34
Share price
0.00%
Change (1 day)
14.40%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
EPS for Catalent (CTLT)
EPS in 2023 (TTM): -$2.09
According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.18. In 2022 the company made an earnings per share (EPS) of $3.84 a decrease over its 2021 EPS that were of $5.53.
EPS history for Catalent from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.09 | -154.5% |
| 2022 | $3.84 | -30.58% |
| 2021 | $5.53 | 79.67% |
| 2020 | $3.08 | 114.12% |
| 2019 | $1.44 | -15% |
| 2018 | $1.69 | 75.44% |
| 2017 | $0.96 | -22.97% |
| 2016 | $1.25 | -59.56% |
| 2015 | $3.09 | 282.05% |
| 2014 | $0.81 | -378.2% |
| 2013 | -$0.29 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $1.34 | -161.24% | 🇺🇸 USA |
 | -$1.27 | -41.86% | 🇺🇸 USA |
 | -$2.38 | 9.30% | 🇮🇪 Ireland |
 | $10.81 | -595.35% | 🇺🇸 USA |